Morphine promotes renal pathology in sickle mice

Area of Science:

• Nephrology
• Pharmacology
• Hematology

Background:

• Sickle cell disease (SCD) patients frequently require opioids for pain management.
• Opioids have known renal effects, but their impact on SCD nephropathy is unclear.
• Long-term opioid use necessitates understanding its renal consequences in SCD.

Purpose of the Study:

• To investigate the effects of chronic morphine on renal health in a mouse model of SCD.
• To determine if opioid receptor antagonism mitigates morphine-induced kidney damage.

Main Methods:

• Mice with pre-existing renal disease and varying sickle hemoglobin levels were treated with morphine.
• Renal morphology was assessed using light and electron microscopy.
• Urine albumin to creatinine ratio and hemeoxygenase-1 levels were measured.

Main Results:

• Morphine induced significant glomerular pathology, including increased volume, mesangial expansion, and podocyte effacement.
• Cystic tubulopathy and hemeoxygenase-1 expression increased with morphine treatment.
• Naloxone, an opioid receptor antagonist, reversed morphine-induced renal defects.

Conclusions:

• Clinically relevant doses of morphine cause significant renal pathology in SCD models.
• Opioid receptor antagonists show potential in preventing or treating morphine-induced nephropathy in SCD.